Neurobiological measures of schizotypal personality disorder: defining an inhibitory endophenotype?
These results suggest that P50 and antisaccade performance reflects a common endophenotype and that prepulse inhibition identifies a separate endophenotype reflecting different neurobiological substrate(s) in subjects with schizotypal personality disorder. This pattern may generalize to schizophrenia spectrum disorder patients.
It was found that former smokers had a risk for donor site complication more than double that of never smokers (OR =2.12, CI =1.10-4.10, p = 0.025). Differences in BMI within the range from 18-33.7 did not have any significant impact on complication rates, neither at the donor site nor at the breast.